Shareholder Resolution Electing Shay Avraham Sarid as Director and Officer of Cannabics Pharmaceuticals Inc.
The majority shareholders of Cannabics Pharmaceuticals Inc. held a special meeting and resolved to elect Shay Avraham Sarid as a new director and officer of the company. Dr. Zohar Koren has stepped down from his director position but will remain involved with the company. This resolution was adopted on January 23, 2015, and will be filed in the corporate records.
Exhibit 99.01
RESOLUTION OF THE SHAREHOLDERS
OF
CANNABICS PHARMACEUTICALS INC.
The following is a true copy of the resolution duly adopted by the Majority of the Shareholders of the Corporation at a special meeting, notice to this meeting having been waived,
WHEREAS there has been presented to and considered by this meeting a Motion to effectuate a new Board of Directors of the Company;
NOW THEREFORE BE IT RESOLVED that the majority of shareholders having considered this matter, and having opened the floor to all those who voice a preference in the issue and pursuant to NRS 78.320, have overwhelmingly decided and RESOLVED that we have elected:
SHAY AVRAHAM SARID
The Above qualified person has been nominated, and has accepted their position as DIRECTOR and OFFICER of the Company.
At the same time, DR. ZOHAR KOREN, has stepped down from his position as Director of the company, though shall continue in his devotion to the affairs of the company.
Said Motion is hereby passed and the corporate books, records and the Company shall file this Resolution in the corporate records.
Dated: 23rd January, 2015
/s/ Itamar Borocho
Itamar Borochov, Director, CEO
on behalf of Cannabics, Inc., Majority Shareholders
